Merck & Co., Inc. (MRK) Deferred Income Tax Expense (Benefit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Merck & Co., Inc. quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
  • Merck & Co., Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$51 M, a 81.6% increase year-over-year.
Deferred Income Tax Expense (Benefit), Trailing 12 Months (USD)
Deferred Income Tax Expense (Benefit), Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$51 M +$226 M +81.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 -$1.9 B -$1.9 B -$331 M -21.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q1 2023 -$277 M +$61 M +18% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 -$1.57 B -$1.57 B -$1.76 B -939% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q1 2022 -$338 M -$356 M -1978% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $187 M $187 M +$753 M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q1 2021 $18 M -$64 M -78% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$566 M -$566 M -$6 M -1.07% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q1 2020 $82 M -$112 M -57.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$560 M -$560 M -$51 M -10% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q1 2019 $194 M +$224 M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$509 M -$509 M +$2.11 B +80.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q1 2018 -$30 M +$24 M +44.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$2.62 B -$2.62 B -$1.1 B -72.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q1 2017 -$54 M +$16 M +22.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$1.52 B -$1.52 B -$757 M -99.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q1 2016 -$70 M +$109 M +60.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$764 M -$764 M +$1.84 B +70.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q1 2015 -$179 M +$125 M +41.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$2.6 B -$2.6 B -$2.27 B -688% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q1 2014 -$304 M -$233 M -328% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$330 M -$330 M -$999 M -149% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q1 2013 -$71 M -$30 M -73.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $669 M $669 M +$2.21 B Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q1 2012 -$41 M +$173 M +80.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$1.54 B -$1.54 B -$445 M -40.8% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-27
Q1 2011 -$214 M -$366 M -241% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 -$1.09 B -$1.09 B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
Q1 2010 $152 M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.